These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
261 related items for PubMed ID: 20962147
1. Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates. Pitz AM, Yu F, Hermsen ED, Rupp ME, Fey PD, Olsen KM. J Clin Microbiol; 2011 Jan; 49(1):269-74. PubMed ID: 20962147 [Abstract] [Full Text] [Related]
3. The Prevalence of Vancomycin-Intermediate Staphylococcus aureus and Heterogeneous VISA Among Methicillin-Resistant Strains Isolated from Pediatric Population in a Turkish University Hospital. Mirza HC, Sancak B, Gür D. Microb Drug Resist; 2015 Oct; 21(5):537-44. PubMed ID: 25919019 [Abstract] [Full Text] [Related]
10. Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant Staphylococcus aureus. Ozmen Capin BB, Tekeli A, Karahan ZC. Microb Drug Resist; 2020 Mar; 26(3):238-244. PubMed ID: 31545160 [Abstract] [Full Text] [Related]
11. Prevalence and molecular characteristics of heterogeneous vancomycin intermediate Staphylococcus aureus in a tertiary care center of northern China. Cheng X, Ma L, Wang Y, Sun W, Su J. Diagn Microbiol Infect Dis; 2024 Mar; 108(3):116180. PubMed ID: 38183897 [Abstract] [Full Text] [Related]
14. Nationwide surveillance of resistance rates of Staphylococcus aureus clinical isolates from Greek hospitals, 2012-2013. Souli M, Karaiskos I, Galani L, Maraki S, Perivolioti E, Argyropoulou A, Charissiadou A, Zachariadou L, Tsiplakou S, Papaioannou V, Tsorlini H, Katsifa H, Baka V, Pantazi P, Paschali A, Kyratsa A, Trikka-Graphakos E, Giannopoulou P, Vogiatzakis E, Moraitou H, Papadogeorgaki H, Avgerinou H, Panagea T, Pantazatou A, Petinaki E, Stamatopoulou G, Toutouza M, Karatzoglou I, Kontopoulou K, Orfanidou M, Karantani I, Fytas P, Tzanetou K, Platsouka E, Kazila P, Chli A, Statiri N, Giamarellou H. Infect Dis (Lond); 2016 Apr; 48(4):287-292. PubMed ID: 26635179 [Abstract] [Full Text] [Related]
15. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals. Sader HS, Jones RN, Rossi KL, Rybak MJ. J Antimicrob Chemother; 2009 Nov; 64(5):1024-8. PubMed ID: 19744978 [Abstract] [Full Text] [Related]
16. [The incidence and risk factors for heterogeneous vancomycin intermediate Staphylococcus aureus]. Feng NN, Wang Q, Song YL, He LX, Zhou CM, Xie HM, Li HY. Zhonghua Nei Ke Za Zhi; 2013 Apr; 52(4):318-22. PubMed ID: 23925360 [Abstract] [Full Text] [Related]
17. High prevalence of a globally disseminated hypervirulent clone, Staphylococcus aureus CC121, with reduced vancomycin susceptibility in community settings in China. Shen P, Zhou K, Wang Y, Song J, Liu Y, Zhou Y, Xiao Y. J Antimicrob Chemother; 2019 Sep 01; 74(9):2537-2543. PubMed ID: 31203362 [Abstract] [Full Text] [Related]
18. Detection of intermediately vancomycin-susceptible and heterogeneous Staphylococcus aureus isolates: comparison of Etest and Agar screening methods. Riederer K, Shemes S, Chase P, Musta A, Mar A, Khatib R. J Clin Microbiol; 2011 Jun 01; 49(6):2147-50. PubMed ID: 21490190 [Abstract] [Full Text] [Related]